メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

βグルカンの世界市場の将来予測

GLOBAL BETA GLUCAN MARKET FORECAST 2018-2026

発行 Inkwood Research 商品コード 636637
出版日 ページ情報 英文 155 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.89円で換算しております。
Back to Top
βグルカンの世界市場の将来予測 GLOBAL BETA GLUCAN MARKET FORECAST 2018-2026
出版日: 2018年05月14日 ページ情報: 英文 155 Pages
概要

当レポートでは、世界のβグルカン市場の将来展望について分析し、製品の特性や市場の構造、主な市場促進・抑制要因、全体的な市場規模の動向見通し (今後9年間分)、原料別・エンドユーザー別・カテゴリー別・地域別の詳細動向、関連産業との連関構造と市場機会、市場競争環境、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場のダイナミクス

  • 市場の定義
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 課題

第5章 原料別の市場

  • 細菌
  • 真菌
  • 酵母
  • 穀物
  • 藻類

第6章 エンドユーザー別の市場

  • 食品・飲料
  • パーソナルケア用品
  • 医薬品
  • 飼料

第7章 カテゴリー別の市場

  • 不溶解性βグルカン
  • 溶解性βグルカン

第8章 主な分析指標

  • ポーターのファイブフォース分析
  • 主な購入基準
    • コスト
    • 栄養成分
    • 原料
    • 用途
  • バリューチェーン分析
    • 原材料サプライヤー
    • メーカー
    • 流通業者
    • エンドユーザー
  • 規制の枠組み
  • 主な傾向
    • 糖尿病患者の増加
    • βグルカンへの投資
  • 投資の見通し
    • 地域別・エンドユーザー別の見通し
  • ベンダー環境
  • 市場機会マトリックス

第9章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、フランス、ドイツ、イタリア、スペインなど)
  • アジア太平洋地域 (中国、インド、日本、韓国、オーストラリアなど)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第10章 競争環境

  • 市場シェア分析 (上位5社)
  • 企業プロファイル
目次
Product Code: 17082

KEY FINDINGS

The Global Beta glucan market is expected to progress with a CAGR of 7.47% over the forecast period of 2018-2026. Factors like rising health concern among consumers, decreasing prices of raw materials, and growing applications of beta-glucans in the food industry are driving this market's growth.

MARKET INSIGHTS

The global beta glucan market is segmented on the basis of category, end-users, and sources. The category segment involves insoluble beta glucan and soluble beta-glucan. The end-users for the beta-glucan market includes sectors like Personal care, food & beverages, animal feed and pharmaceuticals. Various sources for beta-glucan include bacteria, fungus, yeast, cereal and algae.

REGIONAL INSIGHTS

North America, Europe, Asia-Pacific and rest of the world are the key regions into which the global beta-glucan market is segmented. The European beta-glucan market is predicted to reign the global scene throughout the projected years of 2018-2026. Beta-glucan finds potential application in the cosmetic industry, and since Europe is a major hub for cosmetics, the Beta glucan market too is gaining ground in this region. On the other hand, the highest CAGR in the global beta-glucan market is expected from the North American region. Here, the beta-glucan market finds its primary application in the pharmaceutical sector. Growing instances of diseases like cancer and diabetes and increasing number of clinical trials related to beta-glucan are contributing to the market expansion in this region.

COMPETITIVE INSIGHTS

Alltech Biotechnology, Cargill Inc, Chr. Hansen A/S, Garuda International Inc, Kemin Industries, Specialty Biotech Ltd, Milliporesigma (Merck), Ohly, Tate & Lyle Plc, Super Beta Glucan, Koninklijke Dsm N.V, Frutarom, Kerry Group Plc, Lesaffre Human Care and Pharmacon Asa are few of the well-known market companies in this region.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION
  • 2.5. ESTIMATION METHODOLOGY

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. EUROPE HELD A COLOSSAL SHARE OF THE MARKET
    • 3.2.2. UNITED STATES TO WITNESS ROBUST GROWTH DURING THE FORECAST PERIOD
    • 3.2.3. PHARMACEUTICAL- MAJOR MARKET BY END-USER
    • 3.2.4. SOLUBLE BETA GLUCAN HELD MAJOR CHUNK OF THE MARKET BY CATEGORY
    • 3.2.5. CEREALS TO OFFER LUCRATIVE OPPORTUNITIES

4. MARKET DYNAMICS

  • 4.1. MARKET DEFINITION
  • 4.2. DRIVERS
    • 4.2.1. GROWING HEALTH CONCERN AMONG CONSUMERS AND INCREASING HEALTH EXPENDITURE
    • 4.2.2. GROWING APPLICATIONS OF BETA-GLUCAN IN FOOD INDUSTRY
    • 4.2.3. DECREASING PRICES OF MAJOR RAW MATERIAL SOURCES
  • 4.3. RESTRAINTS
    • 4.3.1. VARIOUS SIDE EFFECTS OF CONSUMING BETA GLUCAN
    • 4.3.2. INCONSISTENCY IN REGULATORY NORMS
  • 4.4. OPPORTUNITIES
    • 4.4.1. UNEXPLOITED BETA GLUCAN APPLICATIONS IN COSMETIC AND MEDICINE SECTOR
  • 4.5. CHALLENGES
    • 4.5.1. INCREASE IN COST OF BETA-GLUCAN EXTRACTION PROCESS

5. MARKET BY SOURCE

  • 5.1. BACTERIA
  • 5.2. FUNGUS
  • 5.3. YEAST
  • 5.4. CEREAL
  • 5.5. ALGAE

6. MARKET BY END-USERS

  • 6.1. FOOD AND BEVERAGES
  • 6.2. PERSONAL CARE
  • 6.3. PHARMACEUTICALS
  • 6.4. ANIMAL FEED

7. MARKET BY CATEGORY

  • 7.1. INSOLUBLE BETA GLUCAN
  • 7.2. SOLUBLE BETA GLUCAN

8. KEY ANALYTICS

  • 8.1. PORTERS 5 FORCE MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 8.1.3. BARGAINING POWER OF BUYERS
    • 8.1.4. BARGAINING POWER OF SUPPLIERS
    • 8.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 8.2. KEY BUYING CRITERIA
    • 8.2.1. COST
    • 8.2.2. NUTRITIONAL CONTENT
    • 8.2.3. SOURCE
    • 8.2.4. APPLICATIONS
  • 8.3. VALUE CHAIN ANALYSIS
    • 8.3.1. RAW MATERIAL SUPPLIERS
    • 8.3.2. MANUFACTURING
    • 8.3.3. DISTRIBUTORS/RETAILERS
    • 8.3.4. END-USERS
  • 8.4. REGULATORY FRAMEWORK
  • 8.5. KEY TRENDS
    • 8.5.1. RISING PREVALENCE OF DIABETES
    • 8.5.2. INVESTMENTS IN BETA GLUCAN
  • 8.6. INVESTMENT OUTLOOK
    • 8.6.1. REGIONAL OUTLOOK
    • 8.6.2. END-USERS OUTLOOK
  • 8.7. VENDOR LANDSCAPE
  • 8.8. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. US
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. UK
    • 9.2.2. FRANCE
    • 9.2.3. GERMANY
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. INDIA
    • 9.3.3. JAPAN
    • 9.3.4. SOUTH KOREA
    • 9.3.5. AUSTRALIA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
    • 10.1.1. CARGILL INC (US)
    • 10.1.2. TATE & LYLE (UK)
    • 10.1.3. KERRY GROUP PLC (ISRAEL)
    • 10.1.4. OHLY (GERMANY)
    • 10.1.5. KONINKLIJKE DSM N.V. (NETHERLANDS)
  • 10.2. COMPANY PROFILES
    • 10.2.1. ALLTECH BIOTECHNOLOGY
      • 10.2.1.1. OVERVIEW
      • 10.2.1.2. PRODUCT PORTFOLIO
      • 10.2.1.3. SCOT ANALYSIS
      • 10.2.1.4. STRATEGIC ANALYSIS
    • 10.2.2. CARGILL INC
      • 10.2.2.1. OVERVIEW
      • 10.2.2.2. PRODUCT PORTFOLIO
      • 10.2.2.3. SCOT ANALYSIS
      • 10.2.2.4. STRATEGIC ANALYSIS
    • 10.2.3. CHR. HANSEN A/S
      • 10.2.3.1. OVERVIEW
      • 10.2.3.2. PRODUCT PORTFOLIO
      • 10.2.3.3. SCOT ANALYSIS
      • 10.2.3.4. STRATEGIC ANALYSIS
    • 10.2.4. GARUDA INTERNATIONAL INC
      • 10.2.4.1. OVERVIEW
      • 10.2.4.2. PRODUCT PORTFOLIO
      • 10.2.4.3. SCOT ANALYSIS
      • 10.2.4.4. STRATEGIC ANALYSIS
    • 10.2.5. KEMIN INDUSTRIES
      • 10.2.5.1. OVERVIEW
      • 10.2.5.2. PRODUCT PORTFOLIO
      • 10.2.5.3. STRATEGIC INITIATIVES
      • 10.2.5.4. SCOT ANALYSIS
      • 10.2.5.5. STRATEGIC ANALYSIS
    • 10.2.6. SPECIALTY BIOTECH LTD
      • 10.2.6.1. OVERVIEW
      • 10.2.6.2. PRODUCT PORTFOLIO
      • 10.2.6.3. SCOT ANALYSIS
      • 10.2.6.4. STRATEGIC ANALYSIS
    • 10.2.7. MILLIPORESIGMA (MERCK)
      • 10.2.7.1. OVERVIEW
      • 10.2.7.2. PRODUCT PORTFOLIO
      • 10.2.7.3. SCOT ANALYSIS
      • 10.2.7.4. STRATEGIC ANALYSIS
    • 10.2.8. OHLY
      • 10.2.8.1. OVERVIEW
      • 10.2.8.2. PRODUCT PORTFOLIO
      • 10.2.8.3. STRATEGIC INITIATIVES
      • 10.2.8.4. SCOT ANALYSIS
      • 10.2.8.5. STRATEGIC ANALYSIS
    • 10.2.9. TATE & LYLE PLC
      • 10.2.9.1. OVERVIEW
      • 10.2.9.2. PRODUCT PORTFOLIO
      • 10.2.9.3. STRATEGIC INITIATIVES
      • 10.2.9.4. SCOT ANALYSIS
      • 10.2.9.5. STRATEGIC ANALYSIS
    • 10.2.10. SUPER BETA GLUCAN
      • 10.2.10.1. OVERVIEW
      • 10.2.10.2. PRODUCT PORTFOLIO
      • 10.2.10.3. SCOT ANALYSIS
      • 10.2.10.4. STRATEGIC ANALYSIS
    • 10.2.11. KONINKLIJKE DSM N.V.
      • 10.2.11.1. OVERVIEW
      • 10.2.11.2. PRODUCT PORTFOLIO
      • 10.2.11.3. SCOT ANALYSIS
      • 10.2.11.4. STRATEGIC ANALYSIS
    • 10.2.12. FRUTAROM
      • 10.2.12.1. OVERVIEW
      • 10.2.12.2. PRODUCT PORTFOLIO
      • 10.2.12.3. SCOT ANALYSIS
      • 10.2.12.4. STRATEGIC ANALYSIS
    • 10.2.13. KERRY GROUP PLC
      • 10.2.13.1. OVERVIEW
      • 10.2.13.2. PRODUCT PORTFOLIO
      • 10.2.13.3. STRATEGIC ANALYSIS
      • 10.2.13.4. SCOT ANALYSIS
      • 10.2.13.5. STRATEGIC ANALYSIS
    • 10.2.14. LESAFFRE HUMAN CARE
      • 10.2.14.1. OVERVIEW
      • 10.2.14.2. PRODUCT PORTFOLIO
      • 10.2.14.3. SCOT ANALYSIS
      • 10.2.14.4. STRATEGIC ANALYSIS
    • 10.2.15. PHARMACON ASA
      • 10.2.15.1. OVERVIEW
      • 10.2.15.2. PRODUCT PORTFOLIO
      • 10.2.15.3. STRATEGIC INITIATIVES
      • 10.2.15.4. SCOT ANALYSIS
      • 10.2.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

  • TABLE 1 GLOBAL BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 2 APPLICATIONS OF DIFFERENT BETA GLUCAN IN FOOD PRODUCTION
  • TABLE 3 GLOBAL BETA GLUCAN MARKET BY SOURCE 2018-2026 ($ MILLION)
  • TABLE 4 GLOBAL BACTERIA MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 5 GLOBAL FUNGUS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 6 GLOBAL YEAST MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 7 GLOBAL CEREAL MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 8 GLOBAL ALGAE MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 9 GLOBAL BETA GLUCAN MARKET BY END-USERS 2018-2026 ($ MILLION)
  • TABLE 10 GLOBAL FOOD AND BEVERAGES MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 11 GLOBAL PERSONAL CARE MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 12 GLOBAL PHARMACEUTICALS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 13 GLOBAL ANIMAL FEED MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 14 GLOBAL BETA GLUCAN MARKET BY CATEGORY 2018-2026 ($ MILLION)
  • TABLE 15 GLOBAL INSOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 16 GLOBAL SOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 17 INVESTMENTS IN BETA GLUCAN
  • TABLE 18 GLOBAL BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 19 NORTH AMERICA BETA GLUCAN MARKET BY COUNTRY ($ MILLION)
  • TABLE 20 EUROPE BETA GLUCAN MARKET BY COUNTRY 2018-2026 ($ MILLION)
  • TABLE 21 ASIA PACIFIC BETA GLUCAN MARKET BY COUNTRY 2018-2026 ($ MILLION)
  • TABLE 22 REST OF WORLD BETA GLUCAN MARKET 2018-2026 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL BETA GLUCAN MARKET BY SOURCE 2018-2026 ($ MILLION)
  • FIGURE 2 EUROPE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 3 UNITED STATES BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 4 GLOBAL SOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 5 GLOBAL CEREALS MARKET 2018-2026 ($ MILLION)
  • FIGURE 6 EVOLUTION OF BETA-GLUCAN MARKET
  • FIGURE 7 GROWING HEALTHCARE EXPENDITURE IN UNITED STATES ($ PER CAPITA)
  • FIGURE 8 HEALTHCARE SPENDING PER CAPITA IN 2015 AND 2016
  • FIGURE 9 FUNCTIONAL FOOD AND BEVERAGES SALES IN BRAZIL 2009-2015 ($ BILLION)
  • FIGURE 10 COMMODITY PRICE INDEX OF WHEAT CROPS
  • FIGURE 11 EU OAT PRICES IN 2015 (MAJOR COUNTRIES)
  • FIGURE 12 GLOBAL COSMETICS PRODUCTS MARKET 2015 ($ BILLION)
  • FIGURE 13 GLOBAL BACTERIA MARKET 2018-2026 ($ MILLION)
  • FIGURE 14 GLOBAL FUNGUS MARKET 2018-2026 ($ MILLION)
  • FIGURE 15 GLOBAL YEAST MARKET 2018-2026 ($ MILLION)
  • FIGURE 16 GLOBAL CEREAL MARKET 2018-2026 ($ MILLION)
  • FIGURE 17 GLOBAL ALGAE MARKET 2018-2026 ($ MILLION)
  • FIGURE 18 GLOBAL FOOD AND BEVERAGES MARKET 2018-2026 ($ MILLION)
  • FIGURE 19 GLOBAL PERSONAL CARE MARKET 2018-2026 ($ MILLION)
  • FIGURE 20 GLOBAL PHARMACEUTICALS MARKET 2018-2026 ($ MILLION)
  • FIGURE 21 GLOBAL ANIMAL FEED MARKET 2018-2026 ($ MILLION)
  • FIGURE 22 GLOBAL INSOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 23 GLOBAL SOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 24 GLOBAL NUMBER OF ADULTS WITH DIABETES (IN MILLIONS) (2015 & 2040)
  • FIGURE 25 TOP 10 COUNTRIES WITH NUMBER OF PEOPLE LIVING WITH DIABETES IN MILLION (2015)
  • FIGURE 26 PERCENTAGE INCREMENT OF DIABETES ACROSS REGIONS (2015 TO 2040)
  • FIGURE 27 INVESTMENT PROPOSITION FOR GLOBAL BETA GLUCAN MARKET BY REGION - 2017
  • FIGURE 28 INVESTMENT PROPOSITION FOR GLOBAL BETA GLUCAN MARKET BY END-USERS - 2017
  • FIGURE 29 UNITED STATES BETA GLUCAN MARKET 2018-2026
  • FIGURE 30 CANADA BETA GLUCAN MARKET 2018-2026
  • FIGURE 31 UNITED KINGDOM BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 32 FRANCE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 33 GERMANY BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 34 ITALY BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 35 SPAIN BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 36 REST OF EUROPE BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 37 CHINA BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 38 INDIA BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 39 JAPAN BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 40 SOUTH KOREA BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 41 AUSTRALIA BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 42 REST OF APAC BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 43 LATIN AMERICA BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 44 MIDDLE EAST AND AFRICA BETA GLUCAN MARKET 2018-2026 ($ MILLION)
  • FIGURE 45 MARKET SHARE ANALYSIS OF TOP COMPANIES IN GLOBAL BETA GLUCAN MARKET - 2017 (%)
Back to Top